Advertisement
Home »

Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort.

Dec 18, 2023

ABOUT THE EXPERTS

  • Akihiko Fukagawa

    Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

    Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

    Natsuko Hama

    Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

    Yasushi Totoki

    Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

    Department of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan.

    Hiromi Nakamura

    Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

    Yasuhito Arai

    Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

    Mihoko Saito-Adachi

    Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

    Akiko Maeshima

    Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.

    Yoshiyuki Matsui

    Department of Urology, National Cancer Center Hospital, Tokyo, Japan.

    Shinichi Yachida

    Department of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan.

    Tetsuo Ushiku

    Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

    Tatsuhiro Shibata

    Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan. tshibata2010@gmail.com.

    Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. tshibata2010@gmail.com.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement